Trial Profile
Chronic Bacterial Prostatitis: Efficacy of Short-lasting Antibiotic Therapy With Prulifloxacin (Unidrox(R)) in Association With Saw Palmetto Extract, Lactobacillus Sporogens and Arbutin (Lactorepens(R))
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Prulifloxacin (Primary)
- Indications Prostatitis
- Focus Therapeutic Use
- 09 Jul 2014 New trial record